|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 403/06 | |
| C07D 207/36 | |||
| A61K 31/4439 | |||
| A61K 31/4025 | |||
| A61P 3/10 | |||
| A61P 25/28 |
| (11) | Patento numeris | 1646625 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04749151.9 |
| Europos patento paraiškos padavimo data | 2004-07-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-04-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2008-07-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/SE2004/001115 |
| Data | 2004-07-08 |
| (87) | Numeris | WO 2005/005416 |
| Data | 2005-01-20 |
| (30) | Numeris | Data | Šalis |
| 0316237 | 2003-07-11 | GB |
| (72) |
HOLM, Patrik, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | PYRROLE-2, 5-DITHIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS |
| PYRROLE-2, 5-DITHIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS |